Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Clinical trial NCT03093831 · TERMINATED
Trial details
- NCT number
- NCT03093831
- Sponsor
- National Cancer Centre, Singapore
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-08
- Primary completion
- 2020-07-17
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.